These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6244868)

  • 1. Effect of benzothiadiazine derivatives on cyclic nucleotide phosphodiesterase and on the tension of the aortic strip.
    Vulliemoz Y; Verosky M; Triner L
    Blood Vessels; 1980; 17(2):91-103. PubMed ID: 6244868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta.
    Lindgren S; Rascón A; Andersson KE; Manganiello V; Degerman E
    Biochem Pharmacol; 1991 Jul; 42(3):545-52. PubMed ID: 1650216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of cyclic AMP and cyclic GMP hydrolysis in rat renal cortex.
    Zenser TV; Craven PA; DeRubertis FR; Davis BB
    Arch Biochem Biophys; 1977 Jan; 178(2):598-606. PubMed ID: 189700
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of cyclic nucleotide phosphodiesterase activity in myometrium from pregnant and spayed rhesus monkeys.
    Beatty CH; Bocek RM; Herrington PT
    J Reprod Fertil; 1979 Mar; 55(2):391-400. PubMed ID: 220417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of a calcium2+-dependent activator of cyclic-nucleotide phosphodiesterase in rat carotid body: effects of hypoxia.
    Hanbauer I; Lovenberg W
    Neuroscience; 1977; 2(4):603-7. PubMed ID: 199858
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
    Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New fluorescent analogs of cAMP and cGMP available as substrates for cyclic nucleotide phosphodiesterase.
    Hiratsuka T
    J Biol Chem; 1982 Nov; 257(22):13354-8. PubMed ID: 6292187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta.
    Saeki T; Saito I
    Biochem Pharmacol; 1993 Sep; 46(5):833-9. PubMed ID: 8396936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterase activity in muscle of patients with carcinoma.
    Canal N; Cerri C; Frattola L; Trabucchi M
    J Neurol Sci; 1979 Nov; 43(3):421-7. PubMed ID: 230321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine.
    Sugden MC; Ashcroft SJ
    Biochem J; 1981 Aug; 197(2):459-64. PubMed ID: 6275834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
    Yu SM; Kuo SC
    Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
    Delpy E; le Monnier de Gouville AC
    Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of cyclic nucleotides in mouse regional brain following 300 ms microwave inactivation.
    Jones DJ; Stavinoha WB
    J Neurochem; 1977 Apr; 28(4):759-63. PubMed ID: 19560
    [No Abstract]   [Full Text] [Related]  

  • 16. Receptor-mediated gonadotropin action in the ovary. Regulatory role of cyclic nucleotide phosphodiesterase(s) in intracellular adenosine 3':5'-cyclic monophosphate turnover and gonadotropin-stimulated progesterone production by rat ovarian cells.
    Azhar S; Menon KM
    Biochem J; 1979 Apr; 180(1):201-11. PubMed ID: 226066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
    Hidaka H; Asano T; Shimamoto T
    Biochim Biophys Acta; 1975 Jan; 377(1):103-16. PubMed ID: 164219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract]   [Full Text] [Related]  

  • 19. Localization of cyclic nucleotide phosphodiesterase in the multicellular stages of Dictyostelium discoideum.
    Brown SS; Rutherford CL
    Differentiation; 1980 Jun; 16(3):173-83. PubMed ID: 6253344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterase activity in normal mice and mice with retinal degeneration.
    Robb RM
    Invest Ophthalmol Vis Sci; 1979 Oct; 18(10):1097-100. PubMed ID: 225287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.